In a population without specific risk factors for thyroid cancer, the benefits of GLP-1 RAs will largely outweigh the harm. The European Medicines Agency in October 2023 announced that they did not find a causal link between GLP-1s and thyroid cancer after a months-long review
This is because sometimes you may not be aware of a side effect of medication or surgery immediately
Part D plans canand often docover GLP-1s if those drugs are FDA-approved and prescribed for a medical condition other than obesity
However, like other drugs in its class, tirzepatide shares a similar safety profile, with specific side effects that patients should be aware of
Comparing Semaglutide and Tirzepatide for Gallstone Risk Semaglutide activates only the GLP-1 receptor, producing steady appetite suppression and moderate weight loss (815% in clinical trials)
A practical, three-step approach adapted from current World Health Organization (56), American College of Sports Medicine (57), American Diabetes Association (58), and European Association for the Study of Obesity (59) guidelines is recommended: (1) introduce regular movement gradually, targeting 150 minutes of moderate-intensity or 75 minutes of vigorous aerobic activity per week (60)
